ID   UD13_RAT                Reviewed;         531 AA.
AC   Q64637;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   24-JUL-2024, entry version 123.
DE   RecName: Full=UDP-glucuronosyltransferase 1A3 {ECO:0000305};
DE            Short=UGT1A3;
DE            EC=2.4.1.17 {ECO:0000250|UniProtKB:P35503};
DE   AltName: Full=B3;
DE   AltName: Full=UDP-glucuronosyltransferase 1-3;
DE            Short=UDPGT 1-3;
DE            Short=UGT1*3;
DE            Short=UGT1-03;
DE            Short=UGT1.3;
DE   Flags: Precursor;
GN   Name=Ugt1a3 {ECO:0000312|RGD:1549728}; Synonyms=Ugt1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-286.
RC   STRAIN=Wistar;
RX   PubMed=7608130; DOI=10.1093/jb/117.2.392;
RA   Emi Y., Ikushiro S., Iyanagi T.;
RT   "Drug-responsive and tissue-specific alternative expression of multiple
RT   first exons in rat UDP-glucuronosyltransferase family 1 (UGT1) gene
RT   complex.";
RL   J. Biochem. 117:392-399(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 287-531.
RC   TISSUE=Liver;
RX   PubMed=2112380; DOI=10.1016/0006-291x(90)91462-2;
RA   Sato H., Koiwai O., Tanabe K., Kashiwamata S.;
RT   "Isolation and sequencing of rat liver bilirubin UDP-
RT   glucuronosyltransferase cDNA: possible alternate splicing of a common
RT   primary transcript.";
RL   Biochem. Biophys. Res. Commun. 169:260-264(1990).
CC   -!- FUNCTION: UDP-glucuronosyltransferase (UGT) that catalyzes phase II
CC       biotransformation reactions in which lipophilic substrates are
CC       conjugated with glucuronic acid to increase the metabolite's water
CC       solubility, thereby facilitating excretion into either the urine or
CC       bile. Essential for the elimination and detoxification of drugs,
CC       xenobiotics and endogenous compounds. Catalyzes the glucuronidation of
CC       endogenous estrogen hormones such as estradiol and estrone. Contributes
CC       to bile acid (BA) detoxification by catalyzing the glucuronidation of
CC       BA substrates, which are natural detergents for dietary lipids
CC       absorption. Involved in the glucuronidation of calcidiol, which is the
CC       major circulating form of vitamin D3, essential for the regulation of
CC       calcium and phosphate homeostasis. Involved in the glucuronidation of
CC       the AGTR1 angiotensin receptor antagonists losartan, candesartan and
CC       zolarsartan, which can inhibit the effect of angiotensin II.
CC       {ECO:0000250|UniProtKB:P35503}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glucuronate acceptor + UDP-alpha-D-glucuronate = acceptor
CC         beta-D-glucuronoside + H(+) + UDP; Xref=Rhea:RHEA:21032,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:132367, ChEBI:CHEBI:132368; EC=2.4.1.17;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21033;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + UDP-alpha-D-glucuronate = 17beta-estradiol
CC         3-O-(beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:52460,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16469, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:136641;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52461;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17beta-estradiol + UDP-alpha-D-glucuronate = 17beta-estradiol
CC         17-O-(beta-D-glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:52464,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:16469, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:82961;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52465;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=17alpha-estradiol + UDP-alpha-D-glucuronate = 17alpha-
CC         estradiol 3-O-(beta-D-glucuronate) + H(+) + UDP;
CC         Xref=Rhea:RHEA:52868, ChEBI:CHEBI:15378, ChEBI:CHEBI:17160,
CC         ChEBI:CHEBI:57529, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52869;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=estrone + UDP-alpha-D-glucuronate = estrone 3-O-(beta-D-
CC         glucuronate) + H(+) + UDP; Xref=Rhea:RHEA:52476, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17263, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:136634; Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52477;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=chenodeoxycholate + UDP-alpha-D-glucuronate =
CC         chenodeoxycholoyl-24-O-(beta-D-glucuronate) + UDP;
CC         Xref=Rhea:RHEA:52940, ChEBI:CHEBI:36234, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:136899;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52941;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=deoxycholate + UDP-alpha-D-glucuronate = deoxycholoyl-24-O-
CC         (beta-D-glucuronate) + UDP; Xref=Rhea:RHEA:52948, ChEBI:CHEBI:23614,
CC         ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, ChEBI:CHEBI:136901;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52949;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=lithocholate + UDP-alpha-D-glucuronate = lithocholoyl-24-O-
CC         (beta-D-glucuronate) + UDP; Xref=Rhea:RHEA:52952, ChEBI:CHEBI:29744,
CC         ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, ChEBI:CHEBI:136902;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52953;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hyodeoxycholate + UDP-alpha-D-glucuronate = hyodeoxycholoyl-
CC         24-O-(beta-D-glucuronate) + UDP; Xref=Rhea:RHEA:52956,
CC         ChEBI:CHEBI:58052, ChEBI:CHEBI:58223, ChEBI:CHEBI:58875,
CC         ChEBI:CHEBI:136903; Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52957;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=hyocholate + UDP-alpha-D-glucuronate = hyocholoyl-24-O-(beta-
CC         D-glucuronate) + UDP; Xref=Rhea:RHEA:52960, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:133661, ChEBI:CHEBI:136904;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52961;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=calcidiol + UDP-alpha-D-glucuronate = calcidiol 25-O-(beta-D-
CC         glucuronide) + H(+) + UDP; Xref=Rhea:RHEA:55840, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17933, ChEBI:CHEBI:58052, ChEBI:CHEBI:58223,
CC         ChEBI:CHEBI:139277; Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:55841;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=losartan + UDP-alpha-D-glucuronate = losartan-2-N-beta-D-
CC         glucuronide + UDP; Xref=Rhea:RHEA:63720, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:149504, ChEBI:CHEBI:149507;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63721;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=candesartan + UDP-alpha-D-glucuronate = candesartan-2-N-beta-
CC         D-glucuronide + UDP; Xref=Rhea:RHEA:63728, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:149509, ChEBI:CHEBI:149523;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63729;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=UDP-alpha-D-glucuronate + zolasartan = UDP + zolarsartan-2-N-
CC         beta-D-glucuronide; Xref=Rhea:RHEA:63748, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:149524, ChEBI:CHEBI:149528;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63749;
CC         Evidence={ECO:0000250|UniProtKB:P35503};
CC   -!- SUBUNIT: Homodimers. Homooligomer. Interacts with UGT1A1, UGT1A4,
CC       UGT1A6, UGT1A7, UGT1A8, UGT1A9 and UGT1A10 to form heterodimers.
CC       {ECO:0000250|UniProtKB:P35503}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P22309, ECO:0000250|UniProtKB:P35503}; Single-
CC       pass membrane protein {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=1;
CC         Comment=UGT1A3 is one of the isoforms produced at the UGT1A complex
CC         locus. The UGT1A complex locus produces different isoforms based on
CC         alternative use of promoters, first exons and terminal exons.
CC         {ECO:0000250|UniProtKB:P35503};
CC       Name=1;
CC         IsoId=Q64637-1; Sequence=Displayed;
CC   -!- SIMILARITY: Belongs to the UDP-glycosyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D38067; BAA07262.1; -; Genomic_DNA.
DR   EMBL; M34007; AAA42312.1; ALT_TERM; mRNA.
DR   AlphaFoldDB; Q64637; -.
DR   SMR; Q64637; -.
DR   CAZy; GT1; Glycosyltransferase Family 1.
DR   GlyCosmos; Q64637; 4 sites, No reported glycans.
DR   GlyGen; Q64637; 4 sites.
DR   PhosphoSitePlus; Q64637; -.
DR   AGR; RGD:1549728; -.
DR   RGD; 1549728; Ugt1a3.
DR   InParanoid; Q64637; -.
DR   BRENDA; 2.4.1.17; 5301.
DR   Reactome; R-RNO-156588; Glucuronidation.
DR   Reactome; R-RNO-189483; Heme degradation.
DR   Reactome; R-RNO-9749641; Aspirin ADME.
DR   Reactome; R-RNO-9754706; Atorvastatin ADME.
DR   Reactome; R-RNO-9757110; Prednisone ADME.
DR   PRO; PR:Q64637; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019899; F:enzyme binding; IBA:GO_Central.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0031100; P:animal organ regeneration; IEP:RGD.
DR   GO; GO:0032782; P:bile acid secretion; ISS:UniProtKB.
DR   GO; GO:0052695; P:cellular glucuronidation; ISS:UniProtKB.
DR   GO; GO:0008210; P:estrogen metabolic process; ISS:UniProtKB.
DR   GO; GO:0070640; P:vitamin D3 metabolic process; ISS:UniProtKB.
DR   GO; GO:0052697; P:xenobiotic glucuronidation; ISS:UniProtKB.
DR   CDD; cd03784; GT1_Gtf-like; 1.
DR   Gene3D; 3.40.50.2000; Glycogen Phosphorylase B; 2.
DR   InterPro; IPR050271; UDP-glycosyltransferase.
DR   InterPro; IPR002213; UDP_glucos_trans.
DR   InterPro; IPR035595; UDP_glycos_trans_CS.
DR   PANTHER; PTHR48043; EG:EG0003.4 PROTEIN-RELATED; 1.
DR   PANTHER; PTHR48043:SF157; UDP GLUCURONOSYLTRANSFERASE 1 FAMILY POLYPEPTIDE A3 PRECURSOR-RELATED; 1.
DR   Pfam; PF00201; UDPGT; 1.
DR   SUPFAM; SSF53756; UDP-Glycosyltransferase/glycogen phosphorylase; 1.
DR   PROSITE; PS00375; UDPGT; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Endoplasmic reticulum; Glycoprotein;
KW   Glycosyltransferase; Lipid metabolism; Membrane; Reference proteome;
KW   Signal; Transferase; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..531
FT                   /note="UDP-glucuronosyltransferase 1A3"
FT                   /id="PRO_0000036014"
FT   TRANSMEM        489..505
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        116
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        139
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        293
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        431
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   531 AA;  60140 MW;  ECB0994C6A2C7CEF CRC64;
     MGIQGFLQKL SGLLLLLCAL PWAEGGKVLV FPMEGSHWLS IRDVVRELHA RGHQAVVLAP
     EVTVHIKEED FFTLQTYPVP YTKEEYRHHL LGHLQNFFET EFSLKLVLQT MAAVNNVSTF
     YVRSCRGLLH NTALIQSLNS SSFDVVLTDP FFPCGAVLAM YLRVPAVFFL QSMLCELEFE
     ATNSPNPSSY IPRLLTLNSD HMSFLDRVKN MLYPVPWMYL CHVNYGSLAR LASDLLQREV
     SVVEILRHAS VWLLRKDFVF HYPRPFMPNM VFIGGINCAN RKPLSQEFEA YVNASGEHGI
     VVFSLGSMVS EIPEKKAMEI AEALGRIPQT LLWRYTGTRP SNLAKNTILV KWLPQNDLLG
     HPKARAFITH SGSHGIYEGI CNGVPMVMMP LFGDQMDNAK RMETRGAGVT LNVLEMTADD
     LENALKTVIN NKSYKENIMR LSSLHKDRPI EPLDLAVFWV EYVMRHKGAP HLRPAAHDLT
     WYQYHSLDVI GFLLAIVLTV VFIVYKSCAY GCRKCFGGKG RVKKSHKSKT H
//
